摘要
冠心病是指冠状动脉（冠脉）粥样硬化导致冠脉管腔狭窄或阻塞，和（或）冠脉痉挛导致的心肌缺血缺氧或坏死，可有症状或无症状的心脏病。由于绝大数是在冠脉粥样硬化的基础上所致，故狭义上将冠脉粥样硬化性心脏病简称为冠心病。
出处
《中华全科医师杂志》
2012年第1期26-27,共2页
Chinese Journal of General Practitioners
参考文献6
-
1Topoi E J,Califf R M,Prystowsky E N,et a1.胡大一,周玉杰.译.Topoi心血管病学.北京:人民卫生出版社,2009.
-
2O'Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation, 1989,80:234-244.
-
3Suaya JA, Stason WB, Ades PA, et al. Cardiac rehabilitation and survival in older coronary patients. J Am Coil cardiol, 2009,54: 25 -33.
-
4American association of cardiovascular and pulmonary rehabilitation(AACVPR). Guidelines for cardiac rehabilitation and secondary prevention programs. 4 th . Illinois: Human Kinetics, 2004.
-
5Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease : an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity ), in coliaboration with the American Association of Cardiovascular and Puhnonary Rehabilitation. Circulation, 2005,111:369-376.
-
6Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs : 2007 update : a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation, 2007, 115:2675-282.
同被引文献20
-
1刘兆平.2011美国冠状动脉及其他动脉粥样硬化性血管疾病二级预防指南解读[J].中国医学前沿杂志（电子版）,2012,4(8):67-69. 被引量：15
-
2罗子幸,陈伟强,贺青军.不同年龄急性心肌梗死患者血脂水平分析[J].国际医药卫生导报,2004,10(20):28-29. 被引量：16
-
3血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量：222
-
4庞霞.不同年龄组急性心肌梗死的临床特点[J].心肺血管病杂志,2005,24(2):91-93. 被引量：11
-
5杨有业,张秀明.临床检验方法学评价.北京:人民卫生出版社,2008.
-
6Karthikeyan G,Teo KK,Islam S,et al. Lipid profile,plasmaapolipoproteins, and risk of a first myocardial infarction amongAsians: an analysis from the INTERHEART Study. J Am CollCardiol, 2009, 53:244-253.
-
7Canto JG, Kiefe Cl, Rogers WJ, et al. Number of coronary heartdisease risk factors and mortality in patients with first myocardialinfarction. JAMA, 2011, 306:2120-2127.
-
8Assmann G, Schulte H, Cullen P, et al. Assessing risk ofmyocardial infarction and stroke : new data from the ProspectiveCardiovascular Munster ( PROCAM ) study. Eur J Clin Invest,2007 , 37 :925-932.
-
9Gotto AM Jr. Low high-density lipoprotein cholesterol as a riskfactor in coronary heart disease: a working group report.Circulation, 2001 , 103:2213-2218.
-
10Barter PJ,Caulfield M,Eriksson M,et al. Effects of torcetrapibin patients at high risk for coronary events. N Engl J Med,2007,357:2109-2122.
-
1杨小平,傅绍萱,李蕴山.钙拮抗剂缓解冠脉痉挛的药理学基础[J].中国药理学通报,1990,6(2):83-86. 被引量：3
-
2刘朝中.巯甲丙脯酸对冠脉痉挛时心肌缺血和心功能的影响[J].心功能杂志,1992,4(4):237-241.
-
3付敏,许秀举.参麦注射液对缺氧缺血心肌的营养保护作用[J].中国实用医药,2010,5(8):250-250. 被引量：10
-
4李艳菊,王建军.稳定性冠心病的防治对策[J].中国社区医师（医学专业）,2010,12(34):17-17.
-
5赵慧琴.不同剂量瑞舒伐他汀对老年稳定性冠心病患者治疗效果观察[J].基层医学论坛,2014,18(35):4798-4800. 被引量：3
-
6申露（摘译）.他汀类药物治疗可降低冠脉痉挛风险[J].中华医学信息导报,2008,23(17):12-12.
-
7冠心病是如何发生的？[J].中国健康月刊,2006(6):8-8.
-
8李峰.地高辛中毒16例原因分析[J].河南职工医学院学报,2012,24(3):422-423. 被引量：1
-
9代红朝,贾艳.丹红针联合前列地尔针治疗顽固性心胶痛100例观察[J].中国社区医师（医学专业）,2010,12(19):142-142. 被引量：2
-
10姜红.冠心病患者应合理使用阿司匹林[J].健康促进,2005(4):13-14.
